24–25 Nov 2026
IARC
Europe/Paris timezone

Urinary metabolite signature of 24h urinary Sodium and Potassium excretion

T3-2
Not scheduled
10m
RC 150 - Auditorium (IARC)

RC 150 - Auditorium

IARC

25 avenue Tony Garnier, Lyon, France
Short oral Prevention Interventions, Policy & Public Health Impact Prevention Interventions, Policy & Public Health Impact

Speaker

Naila Aba (IARC)

Description

A high-sodium, low-potassium diet is linked to increased gastric cancer risk, the fifth leading cause of cancer-related death worldwide. However, data on the identification of metabolites related to sodium or potassium exposure are limited. Thus, this study aims to identify urinary metabolites associated with 24-h urinary Sodium and Potassium excretion.

We conducted a study within 363 participants from the EPIC cohort, in which metabolomic profiling was performed using LC-MS untargeted analysis. Urinary metabolomics data underwent quality control, normalization, and batch-effect correction before features from both ionization modes were merged and clustered to reduce dimensionality. Dietary factors associated with urinary sodium, potassium, and sodium-to-potassium ratio were identified using FDR-corrected Spearman correlations. Metabolomic signatures of each biomarker were derived through multivariable screening and stability selection with LASSO penalization in a training set and evaluated using Ridge regression in an independent test set. Predictive performance was assessed using Q² statistics.

Stability selection identified metabolomic signatures comprising 4 features for urinary sodium excretion, 2 features for urinary potassium excretion, and 14 features for the urinary sodium-to-potassium ratio. Annotation of the selected features is currently ongoing. In independent test-set validation, the sodium and potassium signatures showed modest predictive performance (Q² = 0.30, 95% CI: 0.16-0.47 and Q² = 0.39, 95% CI: 0.23-0.56, respectively), whereas the sodium-to-potassium ratio signature demonstrated strong predictive performance (Q² = 0.77, 95% CI: 0.70-0.83).

This study identified novel urinary metabolomic signatures associated with sodium excretion, potassium excretion, and the sodium-to-potassium ratio. The strong predictive performance observed for the sodium-to-potassium ratio highlights its potential as a metabolomics-based biomarker of unbalanced diet. Further work is underway to annotate the selected features and better understand the biological mechanisms linking dietary sodium and potassium intake to disease risk.

Author

Co-authors

Presentation materials

There are no materials yet.